Comparison
Aniracetam vs CDP-Choline
Aniracetam
A fat-soluble racetam ~5-10x more potent than piracetam. Anxiolytic and creativity-enhancing.
CDP-Choline
Cytidine 5'-diphosphocholine. Delivers both choline (for acetylcholine synthesis) and cytidine (for uridine and synaptic membrane synthesis), giving it a dual mechanism that distinguishes it from Alpha-GPC. The most-validated choline source for stroke recovery and age-related cognitive decline.
| Field | Aniracetam | CDP-Choline |
|---|---|---|
| Category | racetam | cholinergic |
| Dose range | 750–1500mg | 250–500mg |
| Half-life | 2h | 56h |
| Onset | 30min | 60min |
| Evidence | EVIDENCEB | EVIDENCEA |
| Safety | ●●●●○ | ●●●●● |
| Legal (US) | USUnscheduled | USOTC |
| PubMed refs | 280 | 420 |
The comparison in plain English
Auto-generated from dataAniracetam and CDP-Choline are both in the racetam (racetam) and cholinergic respectively. Aniracetam A fat-soluble racetam ~5-10x more potent than piracetam. CDP-Choline Cytidine 5'-diphosphocholine.
Bottom line
Aniracetam (evidence B, safety 4/5) has a stronger evidence base than CDP-Choline (evidence A, safety 5/5). CDP-Choline has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Aniracetam if
Aniracetam is the better fit when your goal aligns with its mechanism (Positive allosteric modulator of AMPA receptors, slowing receptor desensitisation and prolonging excitatory signalling) and the dose range (750–1500mg) suits your protocol. Half-life is 2h.
Choose CDP-Choline if
CDP-Choline is the better fit when your goal aligns with its mechanism (Hydrolysed into choline and cytidine in the gut) and the dose range (250–500mg) suits your protocol. Half-life is 56h.